CMKLR1 and COVID-19: Given that chemerin is elevated in most of the pathologies associated with a higher risk of developing severe COVID-19 and seems to be associated with lung inflammation, in the present study, we evaluated the chemerin/ChemR23 system in COVID-19 patients and correlated it with disease severity.